These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 17805013

  • 21. Sodium channels as molecular targets in multiple sclerosis.
    Waxman SG.
    J Rehabil Res Dev; 2002; 39(2):233-42. PubMed ID: 12051467
    [Abstract] [Full Text] [Related]

  • 22. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
    Itoyama Y, Sternberger NH, Webster HD, Quarles RH, Cohen SR, Richardson EP.
    Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
    [Abstract] [Full Text] [Related]

  • 23. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S, Dallenga T, Winkler A, Roemer S, Maruschak B, Siebert H, Brück W, Stadelmann C.
    J Neuroinflammation; 2017 Mar 17; 14(1):57. PubMed ID: 28302146
    [Abstract] [Full Text] [Related]

  • 24. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.
    Tallantyre EC, Bø L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N.
    Brain; 2009 May 17; 132(Pt 5):1190-9. PubMed ID: 19420101
    [Abstract] [Full Text] [Related]

  • 25. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis.
    Geurts JJ, Wolswijk G, Bö L, van der Valk P, Polman CH, Troost D, Aronica E.
    Brain; 2003 Aug 17; 126(Pt 8):1755-66. PubMed ID: 12805104
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Axonal transection in the lesions of multiple sclerosis.
    Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L.
    N Engl J Med; 1998 Jan 29; 338(5):278-85. PubMed ID: 9445407
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
    Lieury A, Chanal M, Androdias G, Reynolds R, Cavagna S, Giraudon P, Confavreux C, Nataf S.
    Glia; 2014 Oct 29; 62(10):1645-58. PubMed ID: 24910450
    [Abstract] [Full Text] [Related]

  • 34. Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.
    Höflich KM, Beyer C, Clarner T, Schmitz C, Nyamoya S, Kipp M, Hochstrasser T.
    Brain Res; 2016 Nov 01; 1650():125-133. PubMed ID: 27592741
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.
    Tanuma N, Sakuma H, Sasaki A, Matsumoto Y.
    Acta Neuropathol; 2006 Aug 01; 112(2):195-204. PubMed ID: 16733654
    [Abstract] [Full Text] [Related]

  • 37. Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
    Waxman SG.
    Nat Rev Neurosci; 2006 Dec 01; 7(12):932-41. PubMed ID: 17115075
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.